Brainstorm Cell Therapeutics
Why Robinhood?
You can watch BCLI and buy or sell other stocks, ETFs, and their options commission-free!About BCLI
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function.
BCLI Key Statistics
Stock Snapshot
Brainstorm Cell Therapeutics(BCLI) stock is priced at $0.66, giving the company a market capitalization of 53.01M. It carries a P/E multiple of -15.25.
On 2026-05-02, Brainstorm Cell Therapeutics(BCLI) stock moved within a range of $0.62 to $0.67. With shares now at $0.66, the stock is trading +6.0% above its intraday low and -1.9% below the session's peak.
Trading volume for Brainstorm Cell Therapeutics(BCLI) stock has reached 109, versus its average volume of 385.89K.
The stock's 52-week range extends from a low of $0.13 to a high of $0.79.
The stock's 52-week range extends from a low of $0.13 to a high of $0.79.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.